Jiangsu Hengrui Medicine Co., Ltd.

This study tests a new drug, FH-006, in 200 women aged 18-75 with advanced solid tumors that have not responded to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors or slow their growth. Participants will be closely monitored for side …

This early-stage study tests a new injectable drug called SHR-3167 in 55 adults with type 2 diabetes. The goal is to measure how the drug moves through the body and how it affects blood sugar levels. Researchers will also monitor for side effects, including low blood sugar events…

This study tests a new, long-lasting painkiller (bupivacaine liposome) given as a nerve block before chest surgery. It aims to reduce pain during coughing and movement for up to 72 hours after the procedure. About 96 adults having lung surgery will take part. The goal is to find …